https://www.medscape.com/viewarticle/986692
0
0
1/9/23 at 10:03pm
Organization
Medscape
A 2022 guideline for treating diabetes in people with chronic kidney disease highlighted the proven value of three underused drug classes and triggered concern over equitable access to these agents.
Create an account
or login to join the discussion